BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 1681965)

  • 1. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity.
    Bugajski J; Turoń M; Gadek-Michalska A; Borycz JA
    J Physiol Pharmacol; 1991 Mar; 42(1):93-103. PubMed ID: 1681965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers impair the pituitary-adrenocortical responses to central adrenergic receptors stimulation.
    Borycz J; Bugajski AJ; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 1993 Jun; 44(2):161-70. PubMed ID: 8102911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response.
    Bugajski J; Borycz J; Gadek-Michalska A
    J Physiol Pharmacol; 1998 Jun; 49(2):285-92. PubMed ID: 9670111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of naloxone on central adrenergic stimulation of corticosterone secretion.
    Gadek-Michalska A; Turoń M; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):37-45. PubMed ID: 10481380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central histaminergic mechanisms in the corticosterone response to clonidine.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1993 Sep; 44(3):303-12. PubMed ID: 8241531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of intracerebroventricular met- and leu-enkephalin on corticosterone secretion in rats.
    Gadek-Michalska A; Bugajski J
    Folia Med Cracov; 1996; 37(3-4):3-12. PubMed ID: 9269123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity.
    Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R
    J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J; Bugajski AJ
    J Physiol Pharmacol; 1999 Jun; 50(2):327-34. PubMed ID: 10424727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neurohormone systems.
    Bugajski J
    J Physiol Pharmacol; 1996 Dec; 47(4):559-75. PubMed ID: 9116324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of indomethacin on the acth secretion induced by central stimulation of adrenergic receptors.
    Glód R; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2000 Jun; 51(2):347-57. PubMed ID: 10898105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminergic components in carbachol-induced pituitary-adrenocortical activity.
    Bugajski J; Gadek-Michalska A; Borycz J; Bugajski AJ; Głód R
    J Physiol Pharmacol; 1994 Sep; 45(3):419-28. PubMed ID: 7841454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prostaglandins and the hypothalamic and hippocampal histamine in the clonidine-induced pituitary-adrenocortical response.
    Bugajski J; Gadek-Michalska A; Borycz J; Głód R; Ołowska A
    J Physiol Pharmacol; 1996 Sep; 47(3):487-95. PubMed ID: 8877904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2004 Dec; 55(4):679-703. PubMed ID: 15613736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social crowding stress diminishes the pituitary-adrenocortical and hypothalamic histamine response to adrenergic stimulation.
    Bugajski J; Gadek-Michalska A; Borycz J
    J Physiol Pharmacol; 1993 Dec; 44(4):447-56. PubMed ID: 8123892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single corticosterone pretreatment inhibits the hypothalamic-pituitary-adrenal responses to adrenergic and cholinergic stimulation.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2001 Jun; 52(2):313-24. PubMed ID: 11453110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the central histaminergic systems on the pituitary-adrenocortical response to met-enkephalinamide.
    Bugajski J; Turoón M; Gadek-Michalska A; Ołowska A
    J Physiol Pharmacol; 1995 Sep; 46(3):313-22. PubMed ID: 8527812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
    Finn DP; Hudson AL; Kinoshita H; Coventry TL; Jessop DS; Nutt DJ; Harbuz MS
    J Psychopharmacol; 2004 Mar; 18(1):47-53. PubMed ID: 15107184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.